Main menu:
CIP - Каталогизација у публикацији
Народна библиотека Србије, Београд
61
MD : Medical Data : medicinska revija = medical review / glavni i odgovorni urednik Dušan Lalošević. - Vol. 1, no. 1 (2009)- . - Zemun : Udruženje za kulturu povezivanja Most Art Jugoslavija ; Novi Sad : Pasterovo društvo, 2009- (Beograd : Scripta Internacional). - 30 cm
Dostupno i na: http://www.md-medicaldata.com. - Tri puta godišnje.
ISSN 1821-1585 = MD. Medical Data
COBISS.SR-ID 158558988
Authors
1Zorica Bulat, 1Simona Tatović, 2Aleksandra Repić, 2,3 Petar Bulat
1 Katedra za toksikologiju "Akademik Danilo Soldatović",Univerzitet u Beogradu - Farmaceutski fakultet, Srbija.
2 Institut za medicinu rada Srbije "Dr Dragomir Karajović", Beograd, Srbija.
3 Univerzitet u Beogradu - Medicinski fakultet, Srbija.
• The paper was received on 30.11.2016. / Accepted on 05.12.2016.
Correspondence to:
Zorica Bulat
Katedra za toksikologiju "Akademik Danilo Soldatović",
Univerzitet u Beogradu - Farmaceutski fakultet, Srbija
E-mail: zorica.bulat@pharmacy.bg.ac.rs
Phone: +381 11 3951 252
Abstract
Workplace drug testing is becoming accepted practice in last decades, supported with improvement in safety risk at workplace and reduction of health insurance costs. United States in the first place, Europe and other developing countries adopted guidelines governing practice in workplace drug testing. These guidelines clearly define substances which must be tested in programs, cut-offvalues of preliminary screening test conducted with immunoassay techniques. Preliminary positive results are necessarily confirmed with quantitative determination of substances using gas or liquid chromatography with mass spectrometry (GC-MS, LC-MS). Quantification of positive preliminary results should be conducted within the same sample/aliquot of sample using GC-MS or LC-MS. Biological specimen of choice is urine, but whole blood, hair, saliva and sweat have been in use, infrequently and in certain cases.
Important parts of workplace drug testing such as: collection, packaging and transport of samples, information of qualitative/quantitative drug results or medical interpretation of results have to be followed by adequately filled form. It contains relevant data: personal info of tested individual, purpose of testing, involved collector, whether integrity of specimen is preserved. Increasing attempts of falsifying drug results nowadays need to be prevented, thus there are developed algorithms for integrity check of the sample.
Proper procedures of entire process in workplace drug testing with supporting documentation is part of “chain of custody”, providing legally defendable results of analysis, or final report.
Key words
workplace drugs testing, chain of custody, urine.
References
UDK: 615.015-053.2
613.25-053.2
COBISS.SR-ID 226160396